In IBD, macrophage activation by ROS, and pathogen- or damage-associated molecular patterns trigger NF-κB and PI3K/AKT signaling, upregulating pro-inflammatory cytokines and enzymes, which drive oxidative damage in healthy tissues 36. Here, NFKB1 is linked to inflammatory bowel disease.